Share on LinkedInShare on LinkedIn

ARTICLE · 22 MAY 2018

A clear mistake in a claim term cannot be corrected through claim construction

Article discusses effects of the decision in the recent FFC case regarding an anticipated infringement of a patent.

AustraliaIntellectual Property

In GlaxoSmithKline Consumer Healthcare Investments (Ireland) (No 2) Limited v Generic Partners Pty Limited [2018] FCAFC 71, the Full Federal Court has found that terms used in claims cannot be interpreted beyond their plain meaning. Such a decision emphasises that great care is required when drafting claims that contain words or phrases that have a well-established meaning in the art.

The primary decision

GlaxoSmithKline Consumer Healthcare Investments (Ireland) (No. 2) Limited (GSK) commenced a proceeding against Apotex Pty Ltd (Apotex) and a separate proceeding against Generic Partners Pty Ltd for anticipated infringement of the claims of Australian Patent No. 2001260212 (the 212 Patent). Apotex and Generic Partners brought cross-claims against GSK seeking to revoke claims 1 to 6, 8 to 11, 13 and 14 of the 212 Patent.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from